Alveolar–arterial gradient

From WikiMD's WELLNESSPEDIA

(Redirected from Alveolar-arterial gradient)

Alveolar–arterial gradient (A-a gradient) is a measure used in medicine to assess the difference between the alveolar concentration of oxygen and the arterial concentration of oxygen. It is a useful indicator of the efficiency of gas exchange in the lungs. The A-a gradient helps in diagnosing the cause of hypoxemia (low blood oxygen levels) and is particularly important in the evaluation of patients with respiratory failure.

Calculation[edit]

The A-a gradient is calculated using the following formula:

PAO2 = (FiO2)(Patm - PH2O) - (PaCO2/RQ)
A-a gradient = PAO2 - PaO2

where:

  • PAO2 = alveolar oxygen pressure
  • FiO2 = fraction of inspired oxygen
  • Patm = atmospheric pressure
  • PH2O = water vapor pressure at body temperature
  • PaCO2 = arterial carbon dioxide pressure
  • RQ = respiratory quotient (usually assumed to be 0.8)
  • PaO2 = arterial oxygen pressure

The normal A-a gradient varies with age and the FiO2 (fraction of inspired oxygen). Generally, a gradient of less than 10-15 mmHg is considered normal for a young adult breathing room air.

Clinical Significance[edit]

An increased A-a gradient suggests a problem with oxygen transfer from the alveoli to the blood. This can be due to several reasons, including pulmonary fibrosis, pulmonary edema, or pulmonary embolism. In contrast, a normal A-a gradient in the presence of hypoxemia suggests a problem with the overall oxygen content of the air or issues with the circulation of blood in the lungs, such as right-to-left shunt or hypoventilation.

Uses[edit]

The A-a gradient is particularly useful in the differential diagnosis of hypoxemia. By determining whether the gradient is increased or normal, healthcare providers can narrow down the potential causes of a patient's respiratory distress. It is also used to monitor the progress of lung diseases and the response to treatment.

Limitations[edit]

The A-a gradient calculation assumes a constant respiratory quotient and does not account for variations in individual physiology or the presence of other gases in the blood. Additionally, accurate measurement requires arterial blood gas analysis, which is invasive.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.